MR

Michael Rosenblatt

Advisor to Biopharma, Venture and Academia

Newton Highlands, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $500,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $7,000,000.00

Education

Lists including Michael

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

Michael Rosenblatt, M.D.

2022

  • Advisor

    2022

FP
Flagship Pioneering

2016

  • Senior Partner

    2021

  • Chief Medical Officer

    2016 - 2022

Merck

2009 - 2016

  • Chief Medical Officer

    2009 - 2016